Published in Law and Health Weekly, January 20th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Chembio Diagnostics.
Report 1: Chembio Diagnostics, Inc. (CEMI) has reported its financial results for the third quarter ended September 30, 2006.
Revenues for the third quarter of 2006 were $1.02 million, an 8% increase over third quarter 2005 revenues of $945,000. The third quarter 2006 net loss attributable to common stockholders was $2.33 million, or $0.21 per share, compared with a net loss attributable to common stockholders of $1.04 million, or $0.13 per share, for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly